Post by
professional11 on Aug 04, 2010 3:52pm
Some thoughts on today's news
Dissapointing news - and the 30% drop in stock price reflects that. The runway needs to be extended. I expect
aggressive layoffs and additional funding. Having said that, Voclosporin will make it to market - in this, I am confident.
I have not sold a share. The additional trial requested is to evaluate inflammation of the eye - this will be relatively quick and will not take 2 or 3 yrs. Lux has the money (they dont have to pay the milestones). The trial design is in place and appropriate to address FDA concerns. The funding for this additional trial has already been approved by the board (they would not be spending millions for a lost cause - of this, I am also confident). The delay is dissapointing and will be ~ 9-12 months.
P11
Comment by
Sivaya on Aug 04, 2010 5:20pm
While I am not happy with today's news, I appreciate your sharing the information you have with us, and thank you for your comments.